University of Sheffield-Led Study Introduces Hope for Women with Deadly Secondary Breast Cancer
The hopes of thousands of women living with an incurable secondary breast cancer (metastatic or state 4 breast cancer) could be raised by a University…
Tag: Oncology
$5.2m to University of Helsinki-led Study Targeting Metastatic Breast Cancer
Academic research centers from Finland and California come together thanks to a Department of Defense Breast Cancer Research Program (BRCP) Breakthrough Award to help advance…
Majority of New Cancer Therapies Not Producing Meaningful Clinical Benefit According to One Meta Analysis
Boston-area researchers representing elite centers from Beth Israel Deaconess Medical Center and Harvard Medical School to Brigham and Women’s Hospital and others recently analyzed 362…
Precision Therapy: Biomarker May Indicate Indolent Breast Cancer
Recent research involving the Southwest Oncology Group (SWOG) Cancer Research Network indicate that patients with metastatic hormone receptor-positive breast cancer who experience low levels of…
Seagen and Genmab Announce FDA Accelerated Approval for Tivdak (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
Seagen and Genmab announced the FDA has granted accelerated approval to Tivdak (tisotumab-vedotin-tftv), its antibody-drug conjugate (ADC) as monotherapy treatment for adult patients with recurrent…